Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks close lower on UK deflation, weak Chinese trade data

Tue, 13th Oct 2015 16:12

(ShareCast News) - The FTSE 100 ended down 28.90 points to 6,342.28 on Tuesday as September data showed the UK experienced deflation and China's exports and imports declined.The Office for National Statistics said the UK consumer price index fell 0.1% year-on-year last month, compared to analysts' estimates for a flat reading in line with August.On a month-on-month comparison, CPI also dropped 0.1% in September following a 0.2% increase in August. Analysts had predicted 0% growth.The main driver of deflation was discounting at clothing stores and falling petrol and diesel prices."As UK year-on-year inflation hit negative territory for only the second time since 1960, the impact of persistent disinflation upon Bank of England decision making will no doubt have been playing into traders mind-sets, sending GBP-USD 130 points lower within two hours," said IG market analyst Joshua Mahony."However, it is also worth bearing in mind that with wages growing at the fastest rate in over a decade, this is a benefit for the consumer and helps make up for all those years where real wages fell repeatedly."Chinese tradeChinese exports decreased 3.7% in September from a year earlier in US dollar terms following a 5.5% drop in August, the General Administration of Customs revealed. Analysts had expected a 6% slide.Imports plunged 20.4% last month, worse than the 15.9% dip predicted, after a 13.8% fall in August.The trade balance, however, unexpectedly widened to $60.34bn in September from $60.24bn a month earlier when a surplus of $47.90bn had been forecast."Chinese trade figures have been a source of concern for some time now, with both dollar-denominated exports and imports having contracted for most of the year when compared to 12 months previous," said Craig Erlam, senior market analyst at Oanda."The biggest concern is the huge decline in imports and while a large part of this can be attributed to the collapse in commodity prices and should therefore ease of in the coming months, there does also appear to be a domestic demand problem as well."McCafferty calls for rate riseBoE policymaker Ian McCafferty has reiterated that interest rates need to rise to allow more scope for cuts in the event of a financial crisis.In a testimony to the Treasury Committee on the hearing of McCafferty's reappointment to the Monetary Policy Committee on Tuesday, he said there was a need to return the Bank Rate far enough above zero "to a level at which it can be an effective instrument" in tightening or loosening policy. Last Thursday, McCafferty voted in favour of raising interest rates to 0.75% from 0.50%. He was once again the only policymaker to recommend the move.Royal Mail tops FTSE fallersRoyal Mail was in the red on news the government has sold its remaining stake in the postal service group to professional investors.Luxury fashion retailer Burberry was under the cosh amid renewed worries about China - to which it is heavily exposed - following disappointing trade figures.Barclays edged lower on reports the bank may name US investment banker Jes Stanley as its new chief executive.Going the other way, SABMiller jumped after the brewer agreed to a £68bn takeover offer from AB InBev.Housebuilders rallied in line with FTSE 250 peer Bellway which gained after posting a 44% jump in full-year profits that beat expectations. Persimmon, Barratt Developments and Taylor Wimpey were both firmly in the black.Pharmaceuticals giant GlaxoSmithKline was also on the front foot after JPMorgan Cazenove upgraded the stock to 'neutral' from 'underweight' and lifted the price target to 1,370p from 1,320p. The bank noted that medium-term consensus earnings per share estimates have fallen 15-18% year-to-date and expectations now look achievable, with downgrades no longer a concern. Market MoverstechMARK 3,034.34 -0.00%FTSE 100 6,341.41 -0.47%FTSE 250 16,902.78 -0.50% FTSE 100 - RisersSABMiller (SAB) 3,949.50p +9.06%GlaxoSmithKline (GSK) 1,328.50p +1.72%Persimmon (PSN) 1,967.00p +1.60%Carnival (CCL) 3,384.00p +1.50%Inmarsat (ISAT) 929.00p +1.42%Berkeley Group Holdings (The) (BKG) 3,250.00p +1.25%International Consolidated Airlines Group SA (CDI) (IAG) 577.00p +1.23%Barratt Developments (BDEV) 633.50p +1.20%easyJet (EZJ) 1,725.00p +1.17%Taylor Wimpey (TW.) 192.70p +1.05% FTSE 100 - FallersRoyal Mail (RMG) 453.30p -4.00%Tesco (TSCO) 194.30p -3.74%G4S (GFS) 248.20p -3.27%Burberry Group (BRBY) 1,427.00p -3.25%Aberdeen Asset Management (ADN) 333.80p -3.11%Standard Chartered (STAN) 739.40p -3.05%Johnson Matthey (JMAT) 2,520.00p -2.85%Sainsbury (J) (SBRY) 263.80p -2.73%Old Mutual (OML) 205.30p -2.61%Glencore (GLEN) 118.00p -2.60% FTSE 250 - RisersMichael Page International (MPI) 483.50p +4.16%Bellway (BWY) 2,453.00p +3.50%Spire Healthcare Group (SPI) 368.30p +3.40%Sophos Group (SOPH) 231.90p +3.25%Auto Trader Group (AUTO) 330.00p +2.96%Crest Nicholson Holdings (CRST) 540.50p +2.85%Virgin Money Holdings (UK) (VM.) 399.90p +2.51%BTG (BTG) 573.00p +2.32%CLS Holdings (CLI) 1,790.00p +2.11%Vectura Group (VEC) 165.10p +2.10% FTSE 250 - FallersKaz Minerals (KAZ) 135.40p -6.30%Evraz (EVR) 89.20p -5.56%Weir Group (WEIR) 1,284.00p -4.75%IMI (IMI) 1,012.00p -4.17%Vedanta Resources (VED) 578.50p -4.14%Rotork (ROR) 179.10p -3.92%Home Retail Group (HOME) 144.60p -3.73%Homeserve (HSV) 411.00p -3.54%Bodycote (BOY) 556.50p -3.30%Ashmore Group (ASHM) 282.50p -3.19% FTSE TechMARK - RisersNCC Group (NCC) 260.00p +4.00%Dialight (DIA) 664.00p +1.37%Oxford Biomedica (OXB) 7.38p +1.37%Triad Group (TRD) 31.50p +0.80%Gresham Computing (GHT) 110.50p +0.45%Skyepharma (SKP) 337.25p +0.30% FTSE TechMARK - FallersSarossa (SARS) 1.82p -4.71%SDL (SDL) 383.75p -4.06%Spirent Communications (SPT) 73.25p -2.98%Oxford Instruments (OXIG) 677.00p -0.73%Innovation Group (TIG) 39.50p -0.63%BATM Advanced Communications Ltd. (BVC) 19.75p -0.63%E2V Technologies (E2V) 235.50p -0.63%XP Power Ltd. (DI) (XPP) 1,505.00p -0.33%Ricardo (RCDO) 902.00p -0.28%KCOM Group (KCOM) 90.75p -0.27%
More News
Today 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.